- recruitingTherapeutic confirmatory (Phase III)
A Multicenter, Randomized, Double blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Gel 2% for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects with Gorlin Syndrome
This clinical trial is testing a new skin gel called Patidegib for adults with Gorlin syndrome. Researchers want to see if applying this gel to the face can reduce the number of new basal cell carcinoma skin cancers that develop over a 12-month period compared to a dummy gel.
Netherlands · France · Italy - active not recruitingPHASE3
Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome
This study looks at a gel called Patidegib. It’s for adults with Gorlin syndrome who get lots of skin cancers on their face. We want to see if the gel can stop new skin cancers from growing and if it's safe to use.
United States · France · Germany